Bexagliflozin basic information Active ingredient name: Bexagliflozin Brand name: Brenzavvy, Bexacat (Veterinary) Innovator name THERACOSBIO LLC Approval Date: Jan 20, 2023 Therapeutic activity: Highly specific and potent sodium-glucose co-transporter 2 (SGLT2) inhibitor. SGLT2 is responsible for 60% to 90% of renal glucose re-uptake, and unlike other isoforms such as SGLT1, SGLT2 is mainly […]
API Flash News
Tag: new drug application
Back To Top